Literature DB >> 7213533

Possible mechanisms of action of oxyfedrine as an antianginal drug.

J R Parratt, J E Mackenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7213533      PMCID： PMC1401618          DOI： 10.1111/j.1365-2125.1981.tb00540.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Hemodynamic and metabolic changes during myocardial ischemia.

Authors:  J O Parker
Journal:  Arch Intern Med       Date:  1972-05

2.  Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure.

Authors:  R J Marshall; J R Parratt
Journal:  Clin Exp Pharmacol Physiol       Date:  1974 Mar-Apr       Impact factor: 2.557

3.  Nitroglycerin--the first one hundred years: new facts about an old drug.

Authors:  J R Parratt
Journal:  J Pharm Pharmacol       Date:  1979-12       Impact factor: 3.765

4.  Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity.

Authors:  J E Mackenzie; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

5.  A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335
  5 in total
  2 in total

1.  Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study.

Authors:  L Fananapazir; C Bray
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

2.  Effects of oxyfedrine on regional myocardial blood flow in patients with coronary artery disease.

Authors:  J C Kaski; L Araujo; A Maseri
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.